IL18R1 and cancer: In addition, IL18R1 might be mainly involved in inflammatory bowel disease, PD-L1 (programmed death-ligand 1) expression, and hepatitis B, PD-1 (programmed cell death protein-1) checkpoint pathway in cancer and Th1/Th2 cell differentiation (Figure 5b).